JP

John Pribis

Founder of Solu Therapeutics

Brookline, Massachusetts

Overview

Work Experience

  • Co-founder, Head of Business Strategy

    2024 - Current

  • Co-founder and Head of BD, Strategy, and Operations

    2023 - 2024

  • Founding VP of Strategy and Operations

    2022 - 2023

  • Senior Associate

    2021 - 2023

  • Co-founder, VP Strategy & Operations

    2021 - 2022

  • Co-founder, FL77, Inc (Apriori Bio)

    2020 - 2021

  • Associate

    2019 - 2021

  • Flagship Venture Fellow

    2019 - 2019

  • Graduate Student

    2013 - 2019

    Mechanisms of Antibiotic Resistance and Bacterial Evolvability

  • Director of Tri-Institutional Drug Discovery Program & Research Fellow

    2008 - 2013

    Team leader of a tri-institutional drug discovery program that led to the discovery of several drugs to treat sterile inflammation. Inflammation, traumatic injury, and susceptibility to infection after injury.

Relevant Websites